Syntrophin isoforms play specific functional roles in the α 1D-adrenergic receptor/DAPC signalosome

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 596-601

  Lyssand, John S ^a   Lee, Kyung Soon ^a   DeFino, Mia ^a   Adams, Marvin E ^b   Hague, Chris ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

1 adrenergic receptor; Adrenergic; Dystrophin associated protein complex; G protein coupled receptor; Pharmacology; Signalosome; Syntrophin

Indexed keywords

ALPHA 1D ADRENERGIC RECEPTOR; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; RADIOLIGAND; SYNTROPHIN; SYNTROPHIN ALPHA; SYNTROPHIN BETA 1; SYNTROPHIN BETA 2; UNCLASSIFIED DRUG;

AGONIST; ARTICLE; BINDING AFFINITY; BINDING SITE; CYTOSOL; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX; DYSTROPHIN-ASSOCIATED PROTEINS; HEK293 CELLS; HUMANS; LIGANDS; MICE; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

EID: 80052612163     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.004     Document Type: Article

References (19)

1. Guimaraes S., Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 2001, 53:319-356.
2. Raskind M.A., Dobie D.J., Kanter E.D., Petrie E.C., Thompson C.E., Peskind E.R. The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases. J. Clin. Psychiatry 2000, 61:129-133.
3. Hague C., Chen Z., Pupo A.S., Schulte N.A., Toews M.L., Minneman K.P. The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression. J. Pharmacol. Exp. Ther. 2004, 309:388-397.
4. Hague C., Uberti M.A., Chen Z., Hall R.A., Minneman K.P. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. J. Biol. Chem. 2004, 279:15541-15549.
5. Lyssand J.S., DeFino M.C., Tang X.B., Hertz A.L., Feller D.B., Wacker J.L., Adams M.E., Hague C. Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. J. Biol. Chem. 2008, 283:18792-18800.
6. Kojima Y., Sasaki S., Shinoura H., Hayashi Y., Tsujimoto G., Kohri K. Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients. Prostate 2006, 66:761-767.
7. Methven L., Simpson P.C., McGrath J.C. Alpha1A/B-knockout mice explain the native alpha1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other alpha1-subtypes. Br. J. Pharmacol. 2009, 158:1663-1675.
8. Lyssand J.S., Whiting J.L., Lee K.S., Kastl R., Wacker J.L., Bruchas M.R., Miyatake M., Langeberg L.K., Chavkin C., Scott J.D., Gardner R.G., Adams M.E., Hague C. Alpha-dystrobrevin-1 recruits alpha-catulin to the alpha1D-adrenergic receptor/dystrophin-associated protein complex signalosome. Proc. Natl. Acad. Sci. USA 2010, 107:21854-21859.
9. Chen Z., Hague C., Hall R.A., Minneman K.P. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. J. Biol. Chem. 2006, 281:12414-12420.
10. Ritter S.L., Hall R.A. Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 2009, 10:819-830.
11. Buckner S.A., Milicic I., Daza A., Lynch J.J., Kolasa T., Nakane M., Sullivan J.P., Brioni J.D. A-315456: a selective alpha(1D)-adrenoceptor antagonist with minimal dopamine D(2) and 5-HT(1A) receptor affinity. Eur. J. Pharmacol. 2001, 433:123-127.
12. Esbenshade T.A., Hirasawa A., Tsujimoto G., Tanaka T., Yano J., Minneman K.P., Murphy T.J. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol. Pharmacol. 1995, 47:977-985.
13. Giardina D., Crucianelli M., Melchiorre C., Taddei C., Testa R. Receptor binding profile of cyclazosin, a new alpha 1B-adrenoceptor antagonist. Eur. J. Pharmacol. 1995, 287:13-16.
14. Kenny B.A., Chalmers D.H., Philpott P.C., Naylor A.M. Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol. 1995, 115:981-986.
15. Yoshio R., Taniguchi T., Itoh H., Muramatsu I. Affinity of serotonin receptor antagonists and agonists to recombinant and native alpha1-adrenoceptor subtypes. Jpn. J. Pharmacol. 2001, 86:189-195.
16. Brown C.M., McGrath J.C., Midgley J.M., Muir A.G., O'Brien J.W., Thonoor C.M., Williams C.M., Wilson V.G. Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Br. J. Pharmacol. 1988, 93:417-429.
17. Minneman K.P., Theroux T.L., Hollinger S., Han C., Esbenshade T.A. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol. Pharmacol. 1994, 46:929-936.
18. Richardson J., Chatwin H., Hirasawa A., Tsujimoto G., Evans P.D. Agonist-specific coupling of a cloned human alpha1A-adrenoceptor to different second messenger pathways. Naunyn Schmiedebergs Arch. Pharmacol. 2003, 367:333-341.
19. Sanders J., Miller D.D., Patil P.N. Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines. J. Pharmacol. Exp. Ther. 1975, 195:362-371.